INTRODUCTION
Microarray technology can simultaneously measure expression levels of thousands or even ten thousands of genes and produce an avalanche of data. It did not take long before scientists avail themselves of this valuable tool in studying variation of genomewide gene expression over different tissue samples, different experimental conditions or different time points of biological process (Brown and Botstein, 1999) .
It is widely recognized that the conditions of the cell and cellular processes are influenced by a large number of genes interwoven into networks, rather than a few genes (Strohman, 2002) . To study individual biological components alone is not sufficient to discover the rules underlying complex biological systems. Therefore, a systems level study of genetic networks and identification of differentially expressed genetic networks holds the key to unraveling the relationship between genotype and phenotype (Xiong, et al., 2004; Khalil and Hill, 2005; Lu et al., 2005) .
The ideal statistics for testing differentially expressed genetic networks should have high power while keeping false positive rates at a specified level. A multivariate statistic for testing differentially expressed genetic networks is Hotelling T 2 statistic (Anderson, 1984; Xiong et al., 2004; Lu et al., 2005) . However, it is a quadratic function on the difference of means of expression levels between two types of tissue samples (e.g. tumor and normal tissue samples), and the difference is a linear function of expression levels. One strategy to improve the power of test statistics is to amplify difference in the means of gene expression. A natural way to amplify such difference is to transform gene expression levels. It is not difficult to show that any linear transformation of gene expression in T 2 statistics will not change their pre-transformation values. To overcome this problem, I propose to use non-linear transformation of means of gene expression in normal tissue ( X X) and abnormal tissue ( Y Y ), i.e. f ð X XÞ and f ð Y Y Þ, expecting statistics based on difference jf ð X XÞ À f ð Y Y Þj will be more powerful than those based on j X X À Y Y j. The main purpose of this report is to develop a statistic framework for constructing non-linear statistics for testing differentially expressed genes or genetic networks and propose several nonlinear statistics for gene expression data analysis. To do so, I first investigate the properties of non-linear transformation, then study how to construct test statistics based on them and derive asymptotic distributions of non-linear test statistics under the null and alternative hypothesis. Since different non-linear tests may have different power, selection of non-linear statistics is critical to the successful application of non-linear tests to gene expression data analysis. I compare the power of several non-linear test statistics and Hotelling T 2 statistic. Finally, to evaluate their performance non-linear test statistics are applied to two real gene expression datasets and simulations are run to obtain type I error and distribution of statistics.
METHODS

Non-linear functions of sample means of gene expressions and their distributions
For convenience of theoretical analysis, I assume that the number of tissue samples is large enough to allow application of large sample theory to gene expression data analysis although in practice the assumption often does not hold. Under this assumption, the sample mean of gene expression will be asymptotically distributed as normal distributions. Let X X be a vector of means of gene expressions. Then, X X will asymptotically have a normal distribution Nðm x ‚ 1 n S x Þ, where
n is the number of tissue samples. Therefore, the distribution of non-linear functions of sample means can be derived from asymptotic theory of nonlinear functions of normal random vectors, a classical in statistical inference (Serfling, 1980 
B and S X are defined as before, n A and n are the number of abnormal and normal tissue samples respectively. The principle behind T 2 test statistics in gene expression data analysis is to compare difference in the means of gene expression in abnormal and normal samples, and that difference, if amplified, may improve power to identify differentially expressed genes or genetic networks. One strategy to amplify the difference is to transform non-linearly the means of gene expressions so that the non-linear difference should be larger. Therefore, the goal is to search for such non-linear transformations. With this goal in mind, I have investigated how difference of non-linear transformation of means can amplify difference of the means in gene expressions. Define Then by Taylor expansion, we have (Bates and Watts, 1980) 
From Equation (1), the difference in the non-linear functions of the means of the gene expressions between abnormal and normal tissues depends on the Jacobian and Hessian matrices of the non-linear functions. If the norm of the coefficient matrix of the vector m y À m x satisfies
which implies that the norm of differences in non-linear functions of the means of the gene expressions between the abnormal and normal tissues is larger than that of the original difference in the means of the gene expressions under this condition. The matrix B + (1/2) H(m y À my) characterizes the strength of non-linearity of the non-linear functions (Bates and Watts, 1980) and hence provides information for searching non-linear functions which can be used to construct non-linear test statistics with high power.
Test statistics
The results of non-linear functions of asymptotically normal random vectors can be used to construct non-linear test statistics for testing differential expressions of genes or genetic networks. The quadratic form X T CX of asymptotically norm random vectors provides a statistic framework for construction of test statistics.
Suppose that there are k genes in the pathway being tested. Let x ij be the expression of the j-th gene in the i-th normal tissue sample and y ij be the expression of the j-th gene in the i-th abnormal tissue sample. Define
The pooled-sample variance-covariance matrix of the indicator variables for the marker genotypes is defined as
T as defined before. Under the null hypothesis, we have B ¼ C and P x ¼ P y . The estimatorL Lcan be obtained by substituting pooled-sample estimation of the covariance matricesŜ S x ‚Ŝ S y and pooled estimation of the Jacobean matriceŝ B B‚Ĉ C into the equation defining the matrix L. For convenience, estimatorL L under the null hypothesis, will be denoted byL L 0 . The non-linear statistics can be defined as
where ðL LÞ À is the generalized inverse of the matrixL
It can be shown (Greenwood and Nikulin, 1996) that under the null hypothesis of no differential expressions of the gene or genetic network, i.e., H 0 : m x ¼ m y , the statistic T N is asymptotically distributed as a central x 2 ðrÞ distribution, and under the alternative hypothesis H a : m x 6 ¼ m y the statistic T N is asymptotically distributed as a non-central x 2 ðrÞ distribution with the following non-centrality parameter:
Now we consider a special vector-valued non-linear function. Let g(x) be a real valued non-linear function and has a non-zero derivative at its mean 
Under this definition, Jacobean matrices B and C have the following simple forms:
Test statistic T N in Equation (2) defines a class of non-linear tests. Various non-linear functions satisfying some regularity conditions can be used to construct the test statistics. Table 1 lists some of non-linear functions used in this study and their corresponding derivatives.
Comparisons of power of non-linear test statistics and the Hotelling's T 2 statistic by approximate formula
To evaluate the performance of non-linear statistics for testing differential expressions of genes or genetic networks, we need to compare the power of the non-linear test statistics and the Hotelling's T 2 statistic. Calculation of the power of non-linear test statistic is based on computation of the noncentrality parameter in Equation (3). The non-centrality parameters can be approximated by Taylor expansion. In the Supplementary material, I show that under some conditions the non-centrality parameters of the non-linear statistics are larger than that of the Hotelling's T 2 statistic. That means that under above assumed conditions the power of the non-linear test statistics is higher than that of Hotelling's T 2 test statistic.
RESULTS
Null distribution of the non-linear test statistics
In the previous sections I have shown that when the sample size is large enough to apply large sample theory, the distribution of the non-linear statistics under the null hypothesis of no differential expressions is asymptotically a central x 2 distribution. To examine the validity of this statement, I performed a series of simulation studies. Two datasets: the expression profiles of seven genes in invasive lobular and ductal carcinomas of breast in which there are 38 invasive ductal carcinoma (IDC) and 21 invasive lobular carcinoma (ILC) patients (Zhao et al., 2004) , and the expression profiles of four genes in 72 lung neuroendocrine tumor samples and 19 normal samples from GEO database at http://www.ncbi.nlm.nih. gov/geo/gds/gds_browse.cgi?gds=619 were used for simulations. The samples in two types of breast cancers, and lung tumor and normal samples were randomly permuted, 100 000 simulations were repeated. In each simulation, the non-linear statistics were calculated. Figure 1A and B plot the histograms of the statistics based on the quadratic and Gaussian transformations applied to breast cancer samples with the theoretical central x 2 distributions superimposed, respectively. Figure 2A and B plot the histograms of the statistics based on the quadratic and Gaussian transformations applied to lung samples with the theoretical central x 2 distributions superimposed, respectively. It can be seen that the distributions of Table 2 summarizes the type I error rates of the non-linear test statistics and the Hotelling T 2 statistic applied to the simulated breast cancer samples and lung samples. It shows that the estimated type I error rates of the non-linear test statistics were not appreciably different from the nominal levels: a ¼ 0.05 and a ¼ 0.01. These results demonstrate that the tests based on quadratic and Gaussian transformation of the expression levels are still valid even for the reasonably small sample sizes.
Power of the non-linear test statistics and
Hotelling's test statistic
In Section 2.3 I showed that under some conditions, the power of some non-linear statistics is higher than that of the Hotelling T 2 statistic using approximation approach. Now the exact analytic methods are used to calculate their power. The power of two non-linear statistics based on quadratic and Gaussian functions and the Hotelling T 2 statistic with the significance level a ¼ 0.001 is shown in Figure 3 . I assume that the variances s 2 x and s 2 y of the gene expression in the normal and abnormal tissue samples are equal to 5 and 1 respectively, and the numbers of both normal and abnormal tissue samples are equal to 100. In Figure 3 , for ease of presentation, I consider the expression of only one gene. Figure 3 plots the power of the test statistics as a function of difference in measure of gene expressions between normal and abnormal tissues, and demonstrates that the non-linear test statistics in general have higher power than the Hotelling's T 2 statistic. The difference in power between the non-linear statistics and the Hotelling's T 2 statistic increases as the difference in gene expression levels between the abnormal and normal tissue samples increases.
Real data examples
To further evaluate the performance of the non-linear test statistics two real datasets were used. One dataset was the gene expression profiles of invasive lobular and ductal carcinomas of breast (Zhao et al., 2004) . There were 38 IDC and 21 ILC patients with over 42 000 genes profiled using cDNA. Specimens were separated by the modified Scarff-Bloom-Richardson method. The non-linear statistics and the Hotelling's T 2 statistic were applied to this dataset for testing differential expressions of two pathways: cell cycle regulation pathway and MKKK pathway between IDC samples and ILC samples. I have taken care that, for better comparison, the number of genes here match that of genes used in calculating type I error rates. Cell cycle regulation pathway includes seven genes: CDC2, CDK7, HK2, KRAS2, PLK1, PRKCA and STAT1, and MKKK pathway includes seven genes: DLK1, MAP3K14, MAP3K3, MAP3K4, MAP3K7, MAP4K3 and MST1. Table 3 lists P-values of T 2 , quadratic and Gaussian non-linear statistics for testing differential expressions of cell cycle regulation and MKKK pathways. In general non-linear statistics show stronger significance.
Another dataset was for lung neuroendocrine tumor and normal gene profiles. There were 72 various tumor samples and 19 normal samples from GEO database. Table 4 lists P-values of the Hotelling's T 2 , quadratic and Gaussian non-linear statistics for testing differential expressions of P53 pathway and Androgen pathway. P53 pathway includes nine genes: BAX, BCL2, CDKN1A, HIF1A, HSPA4, IGFBP3, MDM2, TNFRSF10B and TRAF1. Androgen pathway includes four genes: CDK2, EGFR, FOLH1 and TMEPAI. Again the number of genes here match that used 
